Is PHAS or BTI a better dividend investment in 2026?

PHAS currently yields 2853.07% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: PHAS offers higher current income.

What is the dividend yield difference between PHAS and BTI?

PHAS has a forward dividend yield of 2853.07% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 2847.69 percentage points.

Home › Compare › PHAS vs BTI

PHAS vs BTI: Dividend Comparison 2026

PHAS yields 2853.07% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PHAS wins by $281872346867.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PHAS

● Live price

2853.07%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$281872346867.04M

Annual income

$263,691,193,706,389,300.00

Full PHAS calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — PHAS vs BTI

📍 PHAS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PHAS	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PHAS + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PHAS pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHAS

Annual income on $10K today (after 15% tax)

$242,510.70/yr

After 10yr DRIP, annual income (after tax)

$224,137,514,650,430,900.00/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, PHAS beats the other by $224,137,514,650,428,540.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHAS + BTI for your $10,000?

PHAS: 50%BTI: 50%

100% BTI50/50100% PHAS

Portfolio after 10yr

$140936173433.54M

Annual income

$131,845,596,853,196,050.00/yr

Blended yield

93.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

PHAS

Analyst Ratings

Buy

Hold

Consensus: Buy

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHAS buys

BTI buys

No recent congressional trades found for PHAS or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPHASBTI

Forward yield	2853.07% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$281872346867.04M ✓	$37.7K
Annual income after 10y	$263,691,193,706,389,300.00 ✓	$2,786.64
Total dividends collected	$280611873155.80M ✓	$14.3K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Buy	Buy

Year-by-year: PHAS vs BTI ($10,000, DRIP)

Year	PHAS Portfolio	PHAS Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$296,007	$285,306.70	$11,299	$598.92	+$284.7K → PHAS
2	$8,209,503	$7,892,775.47	$12,794	$703.91	+$8.20M → PHAS
3	$213,363,270	$204,579,102.60	$14,518	$829.07	+$213.35M → PHAS
4	$5,197,428,076	$4,969,129,376.72	$16,513	$978.64	+$5197.41M → PHAS
5	$118,688,009,645	$113,126,761,603.35	$18,827	$1,157.84	+$118687.99M → PHAS
6	$2,541,344,545,416	$2,414,348,375,096.37	$21,518	$1,373.12	+$2541344.52M → PHAS
7	$51,033,223,710,004	$48,313,985,046,408.66	$24,657	$1,632.46	+$51033223.69M → PHAS
8	$961,336,701,807,468	$906,731,152,437,763.20	$28,329	$1,945.74	+$961336701.78M → PHAS
9	$16,991,731,925,840,448	$15,963,101,654,906,456.00	$32,637	$2,325.33	+$16991731925.81M → PHAS
10	$281,872,346,867,038,600	$263,691,193,706,389,300.00	$37,708	$2,786.64	+$281872346867.00M → PHAS

PHAS vs BTI: Complete Analysis 2026

PHAS — Stock

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full PHAS Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this PHAS vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHAS vs SCHD PHAS vs JEPI PHAS vs O PHAS vs KO PHAS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.